BPMC logo

Blueprint Medicines Corporation (BPMC)

Profile

Full Name

Blueprint Medicines Corporation

Ticker

NASDAQ: BPMC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 30, 2015

Indexes

Not included

Website

http://www.blueprintmedicines.com

Employees

682

Key Details

Price

$129.46(0.00%)

Market cap

$8.36B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$508.82M(+104.04% YoY)

Annual EPS

-$1.07(+87.22% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $129.46
    BPMC price is $129.46

    30-Day Relative Volume

    0.00
    BPMC 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    0%
    BPMC {parameterFullLabel} has remained unchanged on Jul 18, 2025

    Price YTD change

    +48.43%
    BPMC price is up +48.43% since January 1st

    Price 1-year change

    +14.1%
    BPMC price is up +14.1% year-on-year

    Price 3-year change

    +146.78%
    BPMC price is up +146.78% over the past 3 years

    Price Range

    Price All-time high

    $129.65
    BPMC price is currently -0.15% below its historical high of $129.65

    Price 3-year low

    $37.82
    BPMC price is currently +242.31% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $8.36B
    BPMC market capitalization is $8.36 billion

    Market cap 3-year change

    +167.01%
    BPMC market capitalization is up +167.01% over the past 3 years

    Market cap All-time high

    $8.36B
    BPMC market capitalization is currently at an all-time high

    Market cap sector rank

    91.47%
    BPMC market capitalization is higher than 91.47% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.24%
    BPMC shares outstanding is up +2.24% year-on-year

    Shares Outstanding 3-Year Change

    +8.2%
    BPMC shares outstanding is up +8.2% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.88
    BPMC beta is 0.88

    200-day SMA

    $99.62
    BPMC price is currently +29.96% above its 200-day simple moving average

    50-day SMA

    $118.77
    BPMC price is currently +9.00% above its 50-day simple moving average

    RSI

    76.62
    BPMC 14-day relative strength index is 76.62

    Volume

    0.00
    BPMC 30-day relative volume is 0.00

    ATR

    $0.63
    BPMC average true range is $0.63

    10-day Historical Volatility

    3.07%
    BPMC 10-day historical volatility is 3.07%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $508.82M
    BPMC annual revenue is $508.82 million

    Revenue Analysts estimate

    $720.59M
    BPMC annual revenue is currently -29.39% lower than the consensus analysts' forecast

    Revenue 1-year change

    +104.04%
    BPMC annual revenue is up +104.04% year-on-year

    Revenue Sector rank

    73.94%
    BPMC annual revenue is higher than 73.94% of companies in Healthcare sector

    EPS

    EPS

    -$1.07
    BPMC annual earnings per share is -$1.07

    EPS Analysts estimate

    -$0.44
    BPMC annual earnings per share is currently +140.99% higher than the consensus analysts' forecast

    EPS 1-year change

    +87.22%
    BPMC annual earnings per share is up +87.22% year-on-year

    EPS Sector rank

    54.42%
    BPMC annual earnings per share is higher than 54.42% of companies in Healthcare sector

    Profit

    Gross profit

    $488.66M
    BPMC annual gross profit is $488.66 million

    Gross margin

    96.04%
    BPMC annual gross profit margin is 96.04%

    Operating profit

    -$212.04M
    BPMC annual operating income is -$212.04 million

    Operating margin

    -41.67%
    BPMC annual operating profit margin is -41.67%

    Net income

    -$67.09M
    BPMC annual net profit is -$67.09 million

    Net margin

    -13.19%
    BPMC annual net profit margin is -13.19%

    Expenses

    Total expenses

    $720.87M
    BPMC annual total expenses is $720.87 million

    Operating expenses

    $700.71M
    BPMC annual total operating expenses is $700.71 million

    Cost of goods sold

    $20.16M
    BPMC annual cost of goods sold is $20.16 million

    Selling, general & administrative expenses

    $359.27M
    BPMC annual SGA is $359.27 million

    Depreciation and amortization

    $16.29M
    BPMC annual depreciation & amortization is $16.29 million

    Interest expense

    $68.81M
    BPMC annual interest expense is $68.81 million

    Income tax

    $1.23M
    BPMC annual income tax is $1.23 million

    EBIT & EBITDA

    EBIT

    $2.94M
    BPMC annual earnings before interest & taxes is $2.94 million

    EBITDA

    $19.23M
    BPMC annual EBITDA is $19.23 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.18B
    BPMC annual total assets is $1.18 billion

    Non current assets

    $437.13M
    BPMC annual long term assets is $437.13 million

    Current assets

    $742.68M
    BPMC annual total current assets is $742.68 million

    Cash and cash equivalents

    $102.01M
    BPMC annual cash & cash equivalents is $102.01 million

    Accounts receivable

    $75.80M
    BPMC annual accounts receivable is $75.80 million

    Inventory

    $13.61M
    BPMC annual inventory is $13.61 million

    Liabilities

    Total liabilities

    $881.15M
    BPMC annual total liabilities is $881.15 million

    Long term liabilities

    $620.35M
    BPMC annual total long term liabilities is $620.35 million

    Current liabilities

    $260.80M
    BPMC annual total current liabilities is $260.80 million

    Accounts payable

    $6.79M
    BPMC annual accounts payable is $6.79 million

    Debt

    Total debt

    $469.11M
    BPMC annual total debt is $469.11 million

    Total debt 1-year change

    +41.09%
    BPMC annual total debt is up +41.09% year-on-year

    Long term debt

    $411.84M
    BPMC annual long term debt is $411.84 million

    Short term debt

    $57.26M
    BPMC annual short term debt is $57.26 million

    Equity & Capital

    Shareholders equity

    $298.67M
    BPMC annual stockholders equity is $298.67 million

    Book value

    $298.67M
    BPMC annual book value is $298.67 million

    Retained earnings

    -$2.41B
    BPMC annual retained earnings is -$2.41 billion

    Working capital

    $481.88M
    BPMC annual working capital is $481.88 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$192.59M
    BPMC annual cash flow from operations is -$192.59 million

    Cash from operations 1-year change

    +55.91%
    BPMC annual cash flow from operations is up +55.91% year-on-year

    Cash from investing

    -$47.50M
    BPMC annual cash flow from investing activities is -$47.50 million

    Cash from investing 1-year change

    -117.33%
    BPMC annual cash flow from investing activities is down -117.33% year-on-year

    Cash from financing

    $273.11M
    BPMC annual cash flow from financing activities is $273.11 million

    Cash from financing 1-year change

    +129.07%
    BPMC annual cash flow from financing activities is up +129.07% year-on-year

    CAPEX

    CAPEX

    $4.63M
    BPMC annual capital expenditures is $4.63 million

    CAPEX 1-year change

    -71.17%
    BPMC annual capital expenditures is down -71.17% year-on-year

    Free Cash Flow

    Free cash flow

    -$197.22M
    BPMC annual free cash flow is -$197.22 million

    Free cash flow 1-year change

    +56.46%
    BPMC annual free cash flow is up +56.46% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    96.04%
    BPMC annual gross profit margin is 96.04%

    Operating margin

    -41.67%
    BPMC annual operating profit margin is -41.67%

    Net margin

    -13.19%
    BPMC annual net profit margin is -13.19%

    ROA & ROE

    ROA

    -6.02%
    BPMC annual return on assets is -6.02%

    ROE

    -31.26%
    BPMC annual return on equity is -31.26%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BPMC price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BPMC price to earnings ratio is unknown

    PB Ratio

    PB ratio

    24.44
    BPMC price to book ratio is 24.44

    PB ratio Sector rank

    96.18%
    BPMC price to book ratio is higher than 96.18% of companies in Healthcare sector

    PS Ratio

    PS ratio

    14.87
    BPMC price to sales ratio is 14.87

    PS ratio Sector rank

    82.31%
    BPMC price to sales ratio is higher than 82.31% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $8.71B
    BPMC enterprise value is $8.71 billion

    Enterprise value Sector rank

    90.97%
    BPMC enterprise value is higher than 90.97% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -131.08
    BPMC EV/EBITDA is -131.08

    EV/EBITDA Sector rank

    1.41%
    BPMC EV/EBITDA is higher than 1.41% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.85
    BPMC annual current ratio is 2.85

    Quick ratio

    2.80
    BPMC annual quick ratio is 2.80

    Leverage

    Debt to equity

    1.30
    BPMC annual debt to equity ratio is 1.30

    Interest coverage ratio

    0.04
    BPMC annual interest coverage ratio is 0.04

    Risk & Stability

    Piotroski F-Score

    3
    BPMC piotroski f-score is 3

    Altman Z-Score

    3.77
    BPMC altman z-score is 3.77

    Analyst ratings

    Recent major analysts updates

    Jun 17, 25 Wells Fargo
    Equal-Weight
    Jun 5, 25 UBS
    Neutral
    Jun 5, 25 Morgan Stanley
    Equal-Weight
    Jun 4, 25 Citigroup
    Neutral
    Jun 3, 25 Wolfe Research
    Peer Perform
    Jun 3, 25 JMP Securities
    Market Perform
    Jun 2, 25 Wedbush
    Neutral
    Jun 2, 25 Scotiabank
    Sector Perform
    Jun 2, 25 Needham
    Hold
    Jun 2, 25 JP Morgan
    Neutral

    Institutional Ownership

    Screeners with BPMC included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks recommended to hold
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Stocks above analysts price target
    • What is the ticker symbol for Blueprint Medicines Corporation?
    • Does Blueprint Medicines Corporation pay dividends?
    • What sector is Blueprint Medicines Corporation in?
    • What industry is Blueprint Medicines Corporation in?
    • What country is Blueprint Medicines Corporation based in?
    • When did Blueprint Medicines Corporation go public?
    • Is Blueprint Medicines Corporation in the S&P 500?
    • Is Blueprint Medicines Corporation in the NASDAQ 100?
    • Is Blueprint Medicines Corporation in the Dow Jones?
    • When was Blueprint Medicines Corporation's last earnings report?
    • When does Blueprint Medicines Corporation report earnings?

    What is the ticker symbol for Blueprint Medicines Corporation?

    The ticker symbol for Blueprint Medicines Corporation is NASDAQ:BPMC

    Does Blueprint Medicines Corporation pay dividends?

    No, Blueprint Medicines Corporation does not pay dividends

    What sector is Blueprint Medicines Corporation in?

    Blueprint Medicines Corporation is in the Healthcare sector

    What industry is Blueprint Medicines Corporation in?

    Blueprint Medicines Corporation is in the Biotechnology industry

    What country is Blueprint Medicines Corporation based in?

    Blueprint Medicines Corporation is headquartered in United States

    When did Blueprint Medicines Corporation go public?

    Blueprint Medicines Corporation's initial public offering (IPO) was on April 30, 2015

    Is Blueprint Medicines Corporation in the S&P 500?

    No, Blueprint Medicines Corporation is not included in the S&P 500 index

    Is Blueprint Medicines Corporation in the NASDAQ 100?

    No, Blueprint Medicines Corporation is not included in the NASDAQ 100 index

    Is Blueprint Medicines Corporation in the Dow Jones?

    No, Blueprint Medicines Corporation is not included in the Dow Jones index

    When was Blueprint Medicines Corporation's last earnings report?

    Blueprint Medicines Corporation's most recent earnings report was on May 1, 2025

    When does Blueprint Medicines Corporation report earnings?

    The next expected earnings date for Blueprint Medicines Corporation is August 1, 2025
    On this page